Abstract
This study highlights that Nrf2 integrates metabolic and epigenetic regulatory networks to dictate tumor progression and that Nrf2 targeting is therapeutically exploitable in HCC treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have